Literature DB >> 24608552

The impact of transforming healthcare delivery on cystic fibrosis outcomes: a decade of quality improvement at Cincinnati Children's Hospital.

Christopher M Siracusa1, Jeanne L Weiland, James D Acton, Amitra K Chima, Barbara A Chini, Andrea J Hoberman, J Denise Wetzel, Raouf S Amin, Gary L McPhail.   

Abstract

BACKGROUND: In 2001, Cincinnati Children's Hospital embarked on a journey to improve healthcare delivery to patients with cystic fibrosis (CF). Data from the Cystic Fibrosis Foundation National Patient Registry revealed our below-average clinical outcomes, prompting us to initiate improvement interventions.
OBJECTIVE: To improve clinical outcomes for patients with CF through a comprehensive quality-improvement approach directed at increasing patient centredness and improving healthcare delivery.
INTERVENTIONS: In 2001, we shared our below-average outcomes with patients, families and care providers. We instituted a quality-improvement steering committee with parental and hospital leadership, and our data-management support was restructured to provide real-time clinical data to monitor our progress. In 2002, our weekly chart conference changed to a prospective planning session and individualised daily schedules were created for inpatients. In 2003, an influenza vaccination campaign was initiated and our infection-control practices were redesigned. In 2005, best-practice guidelines were developed for airway-clearance therapy. In 2007, evidence-based clinical algorithms were designed and implemented and key care-team members were added. MEASUREMENTS: Primary outcome measures were median forced expiratory volume in 1 s per cent predicted (age range 6-17 years) and median body mass index percentile (age range 2-20 years).
RESULTS: From 2000 to 2010, median forced expiratory volume in 1 s increased from 81.7% to 100.1% predicted and median body mass index increased from the 35th to the 55th centile. DISCUSSION: By focusing on specific outcomes, empowering families and patients, effectively using data, and standardising care processes, we transformed the culture and delivery of care for our patients with CF and learned valuable lessons potentially translatable to other chronic-care providers.

Entities:  

Keywords:  Chronic Disease Management; Paediatrics; Patient-Centred Care; Quality Improvement

Mesh:

Year:  2014        PMID: 24608552     DOI: 10.1136/bmjqs-2013-002361

Source DB:  PubMed          Journal:  BMJ Qual Saf        ISSN: 2044-5415            Impact factor:   7.035


  6 in total

1.  Implementation of cystic fibrosis clinical pathways improved physician adherence to care guidelines.

Authors:  Sachinkumar B Singh; Annie U Shelton; Barbara Greenberg; Timothy D Starner
Journal:  Pediatr Pulmonol       Date:  2016-10-31

2.  Seasonal variation of lung function in cystic fibrosis: longitudinal modeling to compare a Midwest US cohort to international populations.

Authors:  Emrah Gecili; Cole Brokamp; Anushka Palipana; Rui Huang; Eleni-Rosalina Andrinopoulou; Teresa Pestian; Erika Rasnick; Ruth H Keogh; Yizhao Ni; John P Clancy; Patrick Ryan; Rhonda D Szczesniak
Journal:  Sci Total Environ       Date:  2021-03-01       Impact factor: 10.753

Review 3.  Tackling the increasing complexity of CF care.

Authors:  Gregory S Sawicki; Christopher H Goss
Journal:  Pediatr Pulmonol       Date:  2015-10

4.  Trans-Atlantic collaboration: applying lessons learned from the US CF Foundation quality improvement initiative.

Authors:  Kathryn A Sabadosa; Marjorie M Godfrey; Bruce C Marshall
Journal:  Orphanet J Rare Dis       Date:  2018-02-08       Impact factor: 4.123

5.  Dynamic predictive probabilities to monitor rapid cystic fibrosis disease progression.

Authors:  Rhonda D Szczesniak; Weiji Su; Cole Brokamp; Ruth H Keogh; John P Pestian; Michael Seid; Peter J Diggle; John P Clancy
Journal:  Stat Med       Date:  2019-12-09       Impact factor: 2.373

6.  An Animated Functional Data Analysis Interface to Cluster Rapid Lung Function Decline and Enhance Center-Level Care in Cystic Fibrosis.

Authors:  Jesse Pratt; Weiji Su; Don Hayes; John P Clancy; Rhonda D Szczesniak
Journal:  J Healthc Eng       Date:  2021-05-10       Impact factor: 2.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.